Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age

Overview

Journal Clin Med Insights Cardiol

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2019 Jan 9

PMID 30618487

Citations 23

Authors

Pupalan Iyngkaran

Danny Liew

Christopher Neil

Andrea Driscoll

Thomas H Marwick

David L Hare

Affiliations

Soon will be listed here.

Abstract

This feature article for the thematic series on congestive heart failure (CHF) readmissions aims to outline important gaps in guidelines for patients with multiple comorbidities and the elderly. Congestive heart failure diagnosis manifests as a 3-phase journey between the hospital and community, during acute, chronic stable, and end-of-life (palliative) phases. This journey requires in variable intensities a combination of multidisciplinary care within tertiary hospital or ambulatory care from hospital outpatients or primary health services, within the general community. Management goals are uniform, ie, to achieve the lowest New York Heart Association class possible, with improvement in ejection fraction, by delivering gold standard therapies within a CHF program. Comorbidities are an important common denominator that influences outcomes. Comorbidities include diabetes mellitus, chronic obstructive airways disease, chronic renal impairment, hypertension, obesity, sleep apnea, and advancing age. Geriatric care includes the latter as well as syndromes such as frailty, falls, incontinence, and confusion. Many systems still fail to comprehensively achieve all aspects of such programs. This review explores these factors.

Citing Articles

Impact of early CVP monitoring on 1-year mortality in patients with congestive heart failure in the ICU: a retrospective analysis based on the MIMIC-IV2.2 database.

Chen J, Que S, Jin G, Zhu Y, Ma B, Hu W BMC Cardiovasc Disord. 2025; 25(1):162.

PMID: 40055591 PMC: 11887090. DOI: 10.1186/s12872-025-04602-1.

Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation.

Wang Y, Lai J, Chen Z, Sun L, Ma Y, Wu J Front Pharmacol. 2024; 15:1475975.

PMID: 39564110 PMC: 11573571. DOI: 10.3389/fphar.2024.1475975.

Understanding Hospital Readmissions: Insights, Patterns, and Interventions for Improvement in Chronic Kidney Disease.

Surasura A, Siva Krishna Pavan Kumar B, Chinamanagonda S, Durga D, Gubbala S Cureus. 2024; 16(5):e59524.

PMID: 38827006 PMC: 11144055. DOI: 10.7759/cureus.59524.

Challenges of Health Data Use in Multidisciplinary Chronic Disease Care: Perspective from Heart Failure Care.

Iyngkaran P, Usmani W, Hanna F, de Courten M J Cardiovasc Dev Dis. 2023; 10(12).

PMID: 38132654 PMC: 10743507. DOI: 10.3390/jcdd10120486.

A population study on factors associated with unintentional falls among Iranian older adults.

Sotoudeh G, Mohammadi R, Mosallanezhad Z, Viitasara E, Soares J BMC Geriatr. 2023; 23(1):860.

PMID: 38102576 PMC: 10724897. DOI: 10.1186/s12877-023-04571-0.

References

Sin D, Fitzgerald F, Parker J, Newton G, Floras J, Bradley T . Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999; 160(4):1101-6. DOI: 10.1164/ajrccm.160.4.9903020. View

Cowie M, Wood D, Coats A, Thompson S, Suresh V, Poole-Wilson P . Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000; 83(5):505-10. PMC: 1760808. DOI: 10.1136/heart.83.5.505. View

Flather M, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G . Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000; 355(9215):1575-81. DOI: 10.1016/s0140-6736(00)02212-1. View

Macintyre K, Capewell S, Stewart S, Chalmers J, Boyd J, Finlayson A . Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000; 102(10):1126-31. DOI: 10.1161/01.cir.102.10.1126. View

Stewart S, Macintyre K, MacLeod M, BAILEY A, Capewell S, McMurray J . Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?. Eur Heart J. 2001; 22(3):209-17. DOI: 10.1053/euhj.2000.2291. View

Mosterd A, Cost B, Hoes A, de Bruijne M, Deckers J, Hofman A . The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001; 22(15):1318-27. DOI: 10.1053/euhj.2000.2533. View

Mosterd A, Reitsma J, Grobbee D . Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?. Heart. 2001; 87(1):75-6. PMC: 1766961. DOI: 10.1136/heart.87.1.75. View

McCullough P, Philbin E, Spertus J, Kaatz S, Sandberg K, Weaver W . Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002; 39(1):60-9. DOI: 10.1016/s0735-1097(01)01700-4. View

Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F . Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J. 2002; 143(1):45-55. DOI: 10.1067/mhj.2002.119608. View

10.

Rich M . Management of heart failure in the elderly. Heart Fail Rev. 2002; 7(1):89-97. DOI: 10.1023/a:1013706023974. View

11.

Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K . Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18):1397-402. DOI: 10.1056/NEJMoa020265. View

12.

Lloyd-Jones D, Larson M, Leip E, Beiser A, DAgostino R, Kannel W . Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002; 106(24):3068-72. DOI: 10.1161/01.cir.0000039105.49749.6f. View

13.

Cleland J, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar J . The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24(5):442-63. DOI: 10.1016/s0195-668x(02)00823-0. View

14.

Pfeffer M, Swedberg K, Granger C, Held P, McMurray J, Michelson E . Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003; 362(9386):759-66. DOI: 10.1016/s0140-6736(03)14282-1. View

15.

Braunstein J, Anderson G, Gerstenblith G, Weller W, Niefeld M, Herbert R . Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003; 42(7):1226-33. DOI: 10.1016/s0735-1097(03)00947-1. View

16.

Fonarow G . The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003; 4 Suppl 7:S21-30. View

17.

Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A . Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J. 2004; 25(4):300-7. DOI: 10.1016/j.ehj.2003.12.012. View

18.

Gwadry-Sridhar F, Flintoft V, Lee D, Lee H, Guyatt G . A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med. 2004; 164(21):2315-20. DOI: 10.1001/archinte.164.21.2315. View

19.

Tinetti M, Bogardus Jr S, Agostini J . Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004; 351(27):2870-4. DOI: 10.1056/NEJMsb042458. View

20.

Heywood J . The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev. 2005; 9(3):195-201. DOI: 10.1007/s10741-005-6129-4. View